Amy Macalintal's guest appearances

Amy Macalintal

beatcancer's podcast

Bruce Lipton

Bernie Siegel

Chris Wark

Peter Osborne

T. Colin Campbell

Becky Kuehn

Elissa Goodman

Ralph Moss

Ty Bollinger

Marilyn Joyce

Ryan Sternagel

Jennifer Jackson

Leigh Erin Connealy

Cherie Calbom

Veronique Desaulniers

OwlTail

Debra Melamed

These tests are for people with a cancer diagnosis that are considering chemotherapy, have had traditional treatment that has failed them, or for someone who has had a reoccurrence. Their tests detect genomic alterations on cancer tumor cells’ DNA. They help your doctor to identify more potential treatment options than other available tests because they analyze all genes known to be relevant in human cancers. The test report includes the identified genomic alterations and provides information on which targeted therapies, immunotherapies, or clinical trials are a match. This personalized approach makes getting the right treatment for your personal cancer possible, saving patients time, money, and the repercussions of negative side-effects from broad-based treatments. They offer 3 different test that must be ordered by your doctor, FoundationOne Heme (for leukemia, lymphoma, and myeloma), FoundationACT (liquid biopsy when a tissue biopsy is not possible), and FoundationOne Cdx (primarily for non-small-cell lung, breast, prostate, colorectal, melanoma, and ovarian cancers)  For more information go to www.foundationmedicine.com.   You can learn more about this test and others by taking the Cancer Free University Course. It is 50% through this link https://beatcancer.org/blog-posts/cancer-free-university-course.

<p>These tests are for people with a cancer diagnosis that are considering chemotherapy, have had traditional treatment that has failed them, or for someone who has had a reoccurrence. Their tests detect genomic alterations on cancer tumor cells’ DNA. They help your doctor to identify more potential treatment options than other available tests because they analyze all genes known to be relevant in human cancers. The test report includes the identified genomic alterations and provides information on which targeted therapies, immunotherapies, or clinical trials are a match.</p> This personalized approach makes getting the right treatment for your personal cancer possible, saving patients time, money, and the repercussions of negative side-effects from broad-based treatments. <p>They offer 3 different test that must be ordered by your doctor, FoundationOne Heme (for leukemia, lymphoma, and myeloma), FoundationACT (liquid biopsy when a tissue biopsy is not possible), and FoundationOne Cdx (primarily for non-small-cell lung, breast, prostate, colorectal, melanoma, and ovarian cancers) </p> For more information go to <a href="http://www.foundationmedicine.com/" rel="nofollow" target="_blank">www.foundationmedicine.com</a>.   You can learn more about this test and others by taking the Cancer Free University Course. It is 50% through this link <a href="https://beatcancer.org/blog-posts/cancer-free-university-course" rel="nofollow" target="_blank">https://beatcancer.org/blog-posts/cancer-free-university-course</a>.

BC-043 Director of Community Outreach, Debra Melamed speaks with Regional Sales Director of Foundation Medicine, Amy Macalintal about their comprehensive genomic profiling tests